530057 VIVANZA

Vivanza Biosciences Share Price

₹3.41 -0.11 (-3.12%)

23 Dec, 2024 09:10

SIP TrendupStart SIP in VIVANZA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -15.38%
  • Over 3 Month -10.26%
  • Over 6 Month -40.9%
  • Over 1 Year -66.86%
SIP Lightning

Smart Investing Starts Here Start SIP with Vivanza Biosciences for Steady Growth!

Invest Now

Vivanza Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Vivanza Biosciences Financials

Vivanza Biosciences Technicals

EMA & SMA

Current Price
₹3.41
-0.11 (-3.12%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹3.67
  • 50 Day
  • ₹3.83
  • 100 Day
  • ₹4.23
  • 200 Day
  • ₹5.39

Resistance and Support

3.48 Pivot Speed
  • R3 3.74
  • R2 3.67
  • R1 3.55
  • S1 3.36
  • S2 3.29
  • S3 3.17

What's your outlook on Vivanza Biosciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivanza Biosciences has an operating revenue of Rs. 16.42 Cr. on a trailing 12-month basis. An annual revenue growth of 53% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 11% is good. The company has a debt to equity of 58%, which is bit higher. From an O'Neil Methodology perspective, the stock has an EPS Rank of 22 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of E is the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivanza Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-17 Quarterly Results
2024-08-08 Quarterly Results
2024-07-05 Others Inter alia, 1) To consider and approve the Director's Report and Secretarial Audit Report along with annexure for the F.Y. 2023-24; split from Rs. 10/- to Re. 1/-.
2024-04-30 Audited Results
2024-02-06 Quarterly Results
Date Purpose Remarks
2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

Vivanza Biosciences F&O

Vivanza Biosciences Shareholding Pattern

39.86%
0%
51.05%
9.09%

About Vivanza Biosciences

  • NSE Symbol
  • VIVANZA
  • BSE Symbol
  • 530057
  • Managing Director
  • Mr. J A Mehta
  • ISIN
  • INE984E01035

Similar Stocks to Vivanza Biosciences

Vivanza Biosciences FAQs

Vivanza Biosciences share price is ₹3 As on 23 December, 2024 | 08:56

The Market Cap of Vivanza Biosciences is ₹13.6 Cr As on 23 December, 2024 | 08:56

The P/E ratio of Vivanza Biosciences is 185.5 As on 23 December, 2024 | 08:56

The PB ratio of Vivanza Biosciences is 2.9 As on 23 December, 2024 | 08:56

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23